Sarepta Therapeutics Announces Approval of Clinical Trial Application for SRP-1005, Its Investigational Treatment for Huntington’s Disease

Sarepta Therapeutics just received approval to begin clinical trials for SRP-1005, an investigational treatment offering new hope to the Huntington's Disease community. This is a significant stride towards potential new therapies! ✨ #HuntingtonsDisease #HDResearch

When DNA Repair Goes Off Script: How a Small Change in FAN1 Can Accelerate Huntington’s Disease – HDBuzz

Two studies reveal how a tiny change in FAN1—a DNA repair protein—weakens its hold on DNA, fueling repeat expansions and speeding up Huntington’s disease symptoms.

en.hdbuzz.net/when-dna-rep...

#HDAwareness #huntingtonsdiseaseawareness #huntingtonsdisease #HDResearch

Read Here: en.hdbuzz.net/unlocking-th...

#HDAwareness #HDResearch #HDCommunity #HealthyLiving #HuntingtonsDisease

Did you know?

Huntington’s disease is thought to affect about 1 in 7000 people. That’s about the same prevalence as ALS!

#HuntingtonsDisease #HDResearch #HealthyLiving #HDCommunity